AstraZeneca had a very strong start in 2024 with substantial Total Revenue growth of 19% in the first quarter.
Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca
Latest presentations
Q1 2024 results
We have
projects in our pipeline